CBCC Global Research

Bakersfield, California 93309

2 studies enrolling now · 5 studies all time

What they study most

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Breast Cancer, Chronic Myelogenous Leukemia, Colorectal Neoplasms, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Neoplasm, Non-Squamous Non-small Cell Lung Cancer

Studies at this site

• A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer — Recruiting now
• A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy — Recruiting now
• Phase III Study of AK112 for NSCLC Patients — Running, not enrolling
• Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy — Completed
• Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer — Completed